Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 20 studies | 31% ± 12% | |
classical monocyte | 17 studies | 28% ± 10% | |
macrophage | 9 studies | 27% ± 10% | |
conventional dendritic cell | 8 studies | 34% ± 10% | |
monocyte | 7 studies | 24% ± 10% | |
dendritic cell | 6 studies | 28% ± 10% | |
epithelial cell | 5 studies | 33% ± 7% | |
enterocyte | 4 studies | 27% ± 6% | |
endothelial cell | 4 studies | 23% ± 3% | |
mononuclear phagocyte | 3 studies | 37% ± 11% | |
glomerular endothelial cell | 3 studies | 22% ± 4% | |
fibroblast | 3 studies | 20% ± 4% | |
type II pneumocyte | 3 studies | 29% ± 14% | |
endothelial cell of vascular tree | 3 studies | 16% ± 1% | |
goblet cell | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 4150.25 | 245 / 245 | 100% | 36.09 | 502 / 502 |
thymus | 100% | 5551.84 | 653 / 653 | 100% | 27.98 | 605 / 605 |
kidney | 100% | 5096.65 | 89 / 89 | 100% | 30.74 | 900 / 901 |
ovary | 100% | 5013.45 | 180 / 180 | 100% | 18.25 | 429 / 430 |
liver | 100% | 4054.92 | 225 / 226 | 100% | 25.73 | 406 / 406 |
stomach | 100% | 3887.36 | 358 / 359 | 100% | 18.71 | 285 / 286 |
intestine | 100% | 6482.15 | 966 / 966 | 99% | 22.43 | 522 / 527 |
bladder | 100% | 4912.57 | 21 / 21 | 99% | 18.66 | 499 / 504 |
breast | 100% | 5282.14 | 459 / 459 | 99% | 25.27 | 1106 / 1118 |
brain | 100% | 6608.84 | 2641 / 2642 | 99% | 36.63 | 697 / 705 |
uterus | 100% | 4161.62 | 170 / 170 | 98% | 19.29 | 452 / 459 |
lung | 99% | 6230.56 | 572 / 578 | 99% | 24.06 | 1147 / 1155 |
adrenal gland | 100% | 4095.48 | 258 / 258 | 98% | 19.23 | 226 / 230 |
skin | 99% | 3556.69 | 1783 / 1809 | 98% | 23.42 | 462 / 472 |
esophagus | 99% | 4154.10 | 1433 / 1445 | 94% | 15.21 | 172 / 183 |
pancreas | 91% | 1789.96 | 299 / 328 | 99% | 25.37 | 176 / 178 |
adipose | 100% | 5784.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4787.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 20.39 | 80 / 80 |
spleen | 100% | 6674.83 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.25 | 1 / 1 |
muscle | 98% | 2869.29 | 787 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 19.50 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 15.60 | 28 / 29 |
heart | 96% | 4489.32 | 826 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 4376.39 | 715 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000233 | Biological process | negative regulation of rRNA processing |
GO_0090068 | Biological process | positive regulation of cell cycle process |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0035863 | Biological process | dITP catabolic process |
GO_0110155 | Biological process | NAD-cap decapping |
GO_0016077 | Biological process | sno(s)RNA catabolic process |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0097383 | Molecular function | dIDP phosphatase activity |
GO_1990174 | Molecular function | phosphodiesterase decapping endonuclease activity |
GO_0031404 | Molecular function | chloride ion binding |
GO_0110153 | Molecular function | RNA NAD-cap (NMN-forming) hydrolase activity |
GO_0140933 | Molecular function | 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0000166 | Molecular function | nucleotide binding |
GO_0030145 | Molecular function | manganese ion binding |
GO_0030515 | Molecular function | snoRNA binding |
GO_0050897 | Molecular function | cobalt ion binding |
GO_1990003 | Molecular function | IDP phosphatase activity |
GO_0035870 | Molecular function | dITP diphosphatase activity |
GO_0008235 | Molecular function | metalloexopeptidase activity |
Gene name | NUDT16 |
Protein name | U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (Nudix hydrolase 16) (U8 snoRNA-binding protein H29K) (m7GpppN-mRNA hydrolase) |
Synonyms | |
Description | FUNCTION: RNA-binding and decapping enzyme that catalyzes the cleavage of the cap structure of snoRNAs and mRNAs in a metal-dependent manner. Part of the U8 snoRNP complex that is required for the accumulation of mature 5.8S and 28S rRNA. Has diphosphatase activity and removes m7G and/or m227G caps from U8 snoRNA and leaves a 5'monophosphate on the RNA. Catalyzes also the cleavage of the cap structure on mRNAs. Does not hydrolyze cap analog structures like 7-methylguanosine nucleoside triphosphate (m7GpppG). Also hydrolysis m7G- and m227G U3-capped RNAs but with less efficiencies. Has broad substrate specificity with manganese or cobalt as cofactor and can act on various RNA species. Binds to the U8 snoRNA; metal is not required for RNA-binding. May play a role in the regulation of snoRNAs and mRNAs degradation. Acts also as a phosphatase; hydrolyzes the non-canonical purine nucleotides inosine diphosphate (IDP) and deoxyinosine diphosphate (dITP) as well as guanosine diphosphate (GDP), deoxyguanosine diphosphate (dGDP), xanthine diphosphate (XDP), inosine triphosphate (ITP) and deoxyinosine triphosphate (ITP) to their respective monophosphate derivatives and does not distinguish between the deoxy- and ribose forms . The order of activity with different substrates is IDP > dIDP >> GDP = dGDP > XDP = ITP = dITP . Binds strongly to GTP, ITP and XTP. Participates in the hydrolysis of dIDP/IDP and probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal lesions . Exhibits decapping activity towards NAD-capped RNAs and FAD-capped RNAs . Exhibits decapping activity towards dpCoA-capped RNAs in vitro (By similarity). . |
Accessions | ENST00000537561.5 [Q96DE0-3] ENST00000521288.2 [Q96DE0-1] Q96DE0 ENST00000502852.1 [Q96DE0-4] |